A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess whether a simple initial dose prescription
of inhaled insulin (Exubera) achieves glycemic control (HbA1c) after 16 weeks that is
non-inferior compared to the standard weight-based formula.